Legal DealFolio - NuVasive Convertible Notes Offering

Davis Polk advised Merrill Lynch, Pierce, Fenner & Smith Incorporated and Goldman, Sachs & Co. as joint book-running managers of the registered public offering by NuVasive, Inc. of $402.5 million aggregate principal amount of its 2.75% convertible senior notes due 2017 (which included the full exercise of the over-allotment option). In addition, Davis Polk advised Bank of America, N.A. and Goldman, Sachs & Co. as counterparties to call spread transactions in connection with the convertible notes offering. NuVasive is a medical device company focused on developing minimally disruptive surgical products and procedures for the spine. The Davis Polk corporate team included partner Alan F. Denenberg, associates Peter M. Lamb and John Dalton and summer associate Grant E. Strother. The equity derivatives team included partners Ray Ibrahim and Mark M. Mendez, associates Derek Dostal, Jonathan Armstrong, Jeong M. Oh and Jonathan B. Brown (not yet admitted) and summer associate Maxwell P. Chapman. Associate Emma Maconick provided intellectual property advice. Partner Rachel D. Kleinberg and associate Catherine Paskoff Chang provided tax advice. Cari M. Hebel and Haniya H. Mir were the legal assistants for the transaction. Members of the Davis Polk team are based in the Menlo Park and New York offices.

Deal Date:	28-06-2011	Practice Area:	Debt Capital Markets
Deal Title:	NuVasive Convertible Notes Offering	Industry:	Healthcare Equipment & Services
Description:	Davis Polk advised Merrill Lynch, Pierce, Fenner & Smith Incorporated and Goldman, Sachs & Co. as joint book-running managers of the registered public offering by NuVasive, Inc. of $402.5 million aggregate principal amount of its 2.75% convertible senior notes due 2017 (which included the full exercise of the over-allotment option). In addition, Davis Polk advised Bank of America, N.A. and Goldman, Sachs & Co. as counterparties to call spread transactions in connection with the convertible notes offering. NuVasive is a medical device company focused on developing minimally disruptive surgical products and procedures for the spine. The Davis Polk corporate team included partner Alan F. Denenberg, associates Peter M. Lamb and John Dalton and summer associate Grant E. Strother. The equity derivatives team included partners Ray Ibrahim and Mark M. Mendez, associates Derek Dostal, Jonathan Armstrong, Jeong M. Oh and Jonathan B. Brown (not yet admitted) and summer associate Maxwell P. Chapman. Associate Emma Maconick provided intellectual property advice. Partner Rachel D. Kleinberg and associate Catherine Paskoff Chang provided tax advice. Cari M. Hebel and Haniya H. Mir were the legal assistants for the transaction. Members of the Davis Polk team are based in the Menlo Park and New York offices.
Financial Center:	Silicon Valley	Value:	100.01-500.00
Advised Party:	Lead Manager	Law Firm	Davis Polk
Issuer Jurisdiction:	United States	Listing Jurisdiction:	United States
Classification:	Equity-Linked Securities Convertible Bonds	Lawyer	Alan F Denenberg

Practice Areas -

Debt Capital Markets Law Firms and Lawyers

Practice Areas - Debt Capital Markets Law Firms and Lawyers